1. Home
  2. STVN vs SEZL Comparison

STVN vs SEZL Comparison

Compare STVN & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • SEZL
  • Stock Information
  • Founded
  • STVN 1949
  • SEZL 2016
  • Country
  • STVN Italy
  • SEZL United States
  • Employees
  • STVN N/A
  • SEZL N/A
  • Industry
  • STVN Containers/Packaging
  • SEZL Diversified Financial Services
  • Sector
  • STVN Consumer Discretionary
  • SEZL Finance
  • Exchange
  • STVN Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • STVN 6.2B
  • SEZL 5.0B
  • IPO Year
  • STVN 2021
  • SEZL N/A
  • Fundamental
  • Price
  • STVN $22.96
  • SEZL $94.60
  • Analyst Decision
  • STVN Buy
  • SEZL Strong Buy
  • Analyst Count
  • STVN 4
  • SEZL 3
  • Target Price
  • STVN $25.13
  • SEZL $124.33
  • AVG Volume (30 Days)
  • STVN 341.4K
  • SEZL 1.4M
  • Earning Date
  • STVN 08-05-2025
  • SEZL 08-07-2025
  • Dividend Yield
  • STVN 0.27%
  • SEZL N/A
  • EPS Growth
  • STVN 6.78
  • SEZL 146.46
  • EPS
  • STVN 0.57
  • SEZL 2.93
  • Revenue
  • STVN $1,344,798,591.00
  • SEZL $371,794,890.00
  • Revenue This Year
  • STVN $8.24
  • SEZL $66.31
  • Revenue Next Year
  • STVN $10.38
  • SEZL $28.42
  • P/E Ratio
  • STVN $40.05
  • SEZL $32.24
  • Revenue Growth
  • STVN 5.28
  • SEZL 92.95
  • 52 Week Low
  • STVN $17.12
  • SEZL $20.74
  • 52 Week High
  • STVN $28.00
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • SEZL 38.16
  • Support Level
  • STVN $21.51
  • SEZL $90.80
  • Resistance Level
  • STVN $23.72
  • SEZL $97.68
  • Average True Range (ATR)
  • STVN 0.84
  • SEZL 5.35
  • MACD
  • STVN 0.09
  • SEZL 1.17
  • Stochastic Oscillator
  • STVN 65.77
  • SEZL 75.49

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: